You just read:

Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)

News provided by

Regeneron Pharmaceuticals, Inc.

Dec 20, 2010, 06:00 EST